Loading...
XKRX200130
Market cap224mUSD
Dec 27, Last price  
11,310.00KRW
1D
-2.67%
1Q
-26.17%
Jan 2017
-39.03%
IPO
100.18%
Name

KolmarBNH Co Ltd

Chart & Performance

D1W1MN
XKRX:200130 chart
P/E
16.77
P/S
0.57
EPS
674.44
Div Yield, %
2.79%
Shrs. gr., 5y
-0.22%
Rev. gr., 5y
8.45%
Revenues
579.55b
+0.63%
0236,186,775,021256,009,784,673337,569,054,611386,365,758,808438,905,517,930606,891,551,147593,080,731,909575,902,994,059579,551,538,020
Net income
19.71b
-51.35%
-825,998,2201,130,065,27829,707,524,79145,771,715,84148,352,739,88554,484,240,35480,484,423,11069,866,436,18040,512,833,05019,709,709,710
CFO
56.28b
+956.80%
-424,305,38717,309,961,70720,684,402,05253,319,627,66122,045,062,46478,203,594,15277,090,164,97171,939,580,0965,325,746,30156,282,493,362
Dividend
Dec 27, 2023308 KRW/sh
Earnings
Mar 17, 2025

Profile

Kolmar BNH Co., Ltd. engages in the research and development of cosmetics, health functional foods, and functional ingredients in South Korea and internationally. It also provides vitamins and minerals, weight control, sports/nutrition, intestinal health, and other products, as well as products for men/women. The company was formerly known as Sun Bio Tech and changed its name to Kolmar BNH Co., Ltd. in 2013. The company was founded in 2004 and is based in Sejong, South Korea. Kolmar BNH Co., Ltd. is a subsidiary of Kolmar Korea Holdings Co., Ltd.
URL
https://www.kolmarbnh.co.kr/
IPO date
Jul 23, 2014
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
579,551,538
0.63%
575,902,994
-2.90%
593,080,732
-2.28%
Cost of revenue
516,088,839
491,491,226
483,137,967
Unusual Expense (Income)
NOPBT
63,462,699
84,411,768
109,942,765
NOPBT Margin
10.95%
14.66%
18.54%
Operating Taxes
7,250,115
15,458,945
23,528,418
Tax Rate
11.42%
18.31%
21.40%
NOPAT
56,212,584
68,952,823
86,414,347
Net income
19,709,710
-51.35%
40,512,833
-42.01%
69,866,436
-13.19%
Dividends
(9,223,749)
(11,498,436)
(9,453,245)
Dividend yield
1.76%
1.38%
1.03%
Proceeds from repurchase of equity
(10,042,070)
BB yield
1.92%
Debt
Debt current
131,696,692
95,300,205
45,966,209
Long-term debt
86,380,643
58,125,309
23,622,079
Deferred revenue
10,965,088
7,489,817
Other long-term liabilities
2,145,178
1,594,684
1,203,204
Net debt
(12,638,752)
(40,156,326)
(158,529,488)
Cash flow
Cash from operating activities
56,282,493
5,325,746
71,939,580
CAPEX
(92,318,929)
(49,646,736)
(48,230,547)
Cash from investing activities
(96,905,604)
(72,989,769)
(93,982,244)
Cash from financing activities
32,847,565
34,278,412
12,609,378
FCF
41,145,862
(61,721,729)
52,299,374
Balance
Cash
86,784,573
107,015,268
171,807,833
Long term investments
143,931,513
86,566,572
56,309,943
Excess cash
201,738,509
164,786,691
198,463,740
Stockholders' equity
59,838,274
393,800,198
363,412,494
Invested Capital
546,731,622
386,931,508
247,610,969
ROIC
12.04%
21.73%
38.58%
ROCE
10.46%
15.29%
24.62%
EV
Common stock shares outstanding
29,222
29,541
29,541
Price
17,940.00
-36.61%
28,300.00
-8.86%
31,050.00
-40.17%
Market cap
524,237,262
-37.29%
836,021,394
-8.86%
917,260,222
-40.17%
EV
509,210,854
796,946,844
759,840,643
EBITDA
79,973,088
98,928,900
121,465,178
EV/EBITDA
6.37
8.06
6.26
Interest
7,383,938
3,186,088
1,846,959
Interest/NOPBT
11.64%
3.77%
1.68%